Sandbox vidit3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<table class="wikitable"> | |||
<tr class="v-firstrow"><th>Drug</th><th>Clinical course</th><th>Stable</th></tr> | |||
<tr><td>Physical examination</td><td> No evidence of heart failure</td></tr> | |||
<tr><td>Functional class</td><td> I/II</td></tr> | |||
<tr><td>6MWD</td><td> Greater than 400 m</td></tr> | |||
<tr><td>Echocardiogram</td><td>RV size normal</td></tr> | |||
<tr><td>Hemodynamics</td><td>RAP normal <br> CI normal</td></tr> | |||
<tr><td>BNP</td><td>Near normal or stable</td></tr> | |||
<tr><td>Treatment</td><td>Oral therapy</td></tr> | |||
<tr><td>Frequency of evaluation </td><td>Q 3 to Q 6 months</td></tr> | |||
<tr><td>FC assessment</td><td> Every clinic visit </td></tr> | |||
<tr><td>6MWT</td><td> Every clinic visit</td></tr> | |||
<tr><td>Echocardiogram<sup>2</sup></td><td>Q 12 months/center dependent</td></tr> | |||
<tr><td>BNP</td><td>center dependent</td></tr> | |||
<tr><td>RHC</td><td>Clinical deterioration and center dependent</td></tr> | |||
</table> | |||
<table class="wikitable"> | |||
<tr class="v-firstrow"><th>Drug</th><th>Clinical course</th><th>Unstable</th></tr> | |||
<tr><td>Physical examination</td><td> Signs of heart failure</td></tr> | |||
<tr><td>Functional class</td><td> IV</td></tr> | |||
<tr><td>6MWD</td><td> Less than 400 m</td></tr> | |||
<tr><td>Echocardiogram</td><td>RV Enlargement</td></tr> | |||
<tr><td>Hemodynamics</td><td>RAP high <br> CI low</td></tr> | |||
<tr><td>BNP</td><td>Elevated/Increasing</td></tr> | |||
<tr><td>Treatment</td><td>Intravenous prostacyclin and/or combination treatment</td></tr> | |||
<tr><td>Frequency of evaluation </td><td>Q 1 to Q 3 months</td></tr> | |||
<tr><td>FC assessment</td><td> Every clinic visit </td></tr> | |||
<tr><td>6MWT</td><td> Every clinic visit</td></tr> | |||
<tr><td>Echocardiogram<sup>2</sup></td><td>Q 6 to Q 12 months/center dependent</td></tr> | |||
<tr><td>BNP</td><td>center dependent</td></tr> | |||
<tr><td>RHC</td><td>Q 6 to Q 12 months or clinical deterioration</td></tr> | |||
</table> | |||
Revision as of 19:28, 9 January 2014
| Drug | Clinical course | Stable |
|---|---|---|
| Physical examination | No evidence of heart failure | |
| Functional class | I/II | |
| 6MWD | Greater than 400 m | |
| Echocardiogram | RV size normal | |
| Hemodynamics | RAP normal CI normal | |
| BNP | Near normal or stable | |
| Treatment | Oral therapy | |
| Frequency of evaluation | Q 3 to Q 6 months | |
| FC assessment | Every clinic visit | |
| 6MWT | Every clinic visit | |
| Echocardiogram2 | Q 12 months/center dependent | |
| BNP | center dependent | |
| RHC | Clinical deterioration and center dependent |
| Drug | Clinical course | Unstable |
|---|---|---|
| Physical examination | Signs of heart failure | |
| Functional class | IV | |
| 6MWD | Less than 400 m | |
| Echocardiogram | RV Enlargement | |
| Hemodynamics | RAP high CI low | |
| BNP | Elevated/Increasing | |
| Treatment | Intravenous prostacyclin and/or combination treatment | |
| Frequency of evaluation | Q 1 to Q 3 months | |
| FC assessment | Every clinic visit | |
| 6MWT | Every clinic visit | |
| Echocardiogram2 | Q 6 to Q 12 months/center dependent | |
| BNP | center dependent | |
| RHC | Q 6 to Q 12 months or clinical deterioration |